A Breathalyzer for Disease
Our Mission: To save 100,000 lives and $1.5B in healthcare costs.
Our Vision: Become the global leader in non‑invasive diagnostics for cancer, infectious disease & inflammatory disease.
Breath Biopsy - VOC Biomarkers in Breath
A non-invasive way to access a patient’s metabolome, for early detection and real time monitoring of disease activity
Learn about breath biopsy
Our Research Products
Bring VOC biomarker research to your own lab with our complete range of R&D instruments
Our research products
Our Research Services
VOC biomarker discovery and validation research services with our world class team and facilities
Our research services
Our Clinical Pipeline
We have an active clinical diagnostics pipeline across oncology and inflammatory diseases for early detection and therapy stratification
View our pipeline
Introducing the FAIMS microchip, revolutionary science at the nanoscale
At Owlstone Medical we have developed a chemical sensor on a silicon chip 100x cheaper and 1000x smaller than existing technologies: the FAIMS microchip.
Breath Biopsy Conference 2018: Cambridge, UK, November 2018
LEARN MORE
Biomarker Services tailored to your needs and clinical objectives
Volatile organic compound (VOC) biomarker discovery and validation for early detection, therapeutic response, drug toxicity and disease monitoring for cancer, inflammatory, and infectious diseases.
SOME OF OUR CUSTOMERS
Breath Biopsy® Complete Guide - VOCs as Biomarkers for Disease
DOWNLOAD FREE EBOOK
Integrate Breath Biopsy into Your Clinical Trial
Taking action to permanently change non-invasive medical diagnostics through innovative clinical projects
We have an active clinical diagnostics pipeline across oncology and inflammatory diseases.